Chemosensitization of Cancer Cells via Gold Nanoparticle‐Induced Cell Cycle Regulation

We have previously shown that plasmonic nanoparticles conjugated with nuclear‐targeting and cytoplasm‐targeting peptides (NLS and RGD, respectively) are capable of altering the cell cycle of human oral squamous carcinoma cells (HSC‐3). In the present work, we show that this regulation of the cell cycle can be exploited to enhance the efficacy of a common chemotherapeutic agent, 5‐Fluorouracil, by pretreating cells with gold nanoparticles. Utilizing flow cytometry cell cycle analysis, we were able to quantify the 5‐Fluorouracil efficacy as an accumulation of cells in the S phase with a depletion of cells in the G2/M phase. Two gold nanoparticle sizes were tested in this work; 30 nm with a surface plasmon resonance at 530 nm and 15 nm with a surface plasmon resonance at 520 nm. The 30 nm nuclear‐targeted gold nanoparticles (NLS‐AuNPs) showed the greatest 5‐Fluorouracil efficacy enhancement when 5‐Fluorouracil treatment (500 μm , 48 h) is preceded by a 24‐h treatment with nanoparticles. In conclusion, we show that nuclear‐targeted 30 nm gold nanoparticles enhance 5‐Fluorouracil drug efficacy in HSC‐3 cells via regulation of the cell cycle, a chemosensitization technique that could potentially be expanded to different cell lines and different chemotherapies.